Paragon 28 is a medical device company focused on the foot and ankle orthopedic market. Co.'s orthopedic solutions, procedural approaches and instrumentation cover a range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity or flatfoot charcot foot and orthobiologics. To treat these conditions, Co. provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Co. has developed a portfolio of foot and ankle surgical systems including plates, screws, nails, joint and bone replacements, orthobiologics, and other implantation instruments and disposables. The FNA stock yearly return is shown above.
The yearly return on the FNA stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the FNA annual return calculation with any dividends reinvested as applicable (on ex-dates).
|